US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

43.68

+0.33100.76%

Post-market: 43.680.00000.00%16:10 EDT

Volume:24.00K

Turnover:1.04M

Market Cap:211.41M

PE:- -

High:43.73

Open:43.54

Low:43.28

Close:43.35

52wk High:47.00

52wk Low:26.52

Shares:4.84M

Float Shares:4.84M

Volume Ratio:1.14

T/O Rate:0.50%

Dividend:0.02

Dividend Rate:0.04%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.

Street View: Revolution's Pancreatic Cancer Drug Nod Sparks a 'transformative' Era

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

Revolution Medicines, Inc. : Oppenheimer Raises Target Price to $260 from $230

THOMSON REUTERS

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Sector Update: Healthcare

MT Newswires Live

Roche receives FDA approval for companion diagnostic tests for Ziihera

Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month

MT Newswires Live

Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports

MT Newswires Live

Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call

THOMSON REUTERS

Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.

THOMSON REUTERS

U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer

THOMSON REUTERS

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease

US FDA Approves Revolution Medicines' Pancreatic Cancer Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CANC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CANC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","market":"US","secType":"STK","nameCN":"TEMA ONCOLOGY ETF","latestPrice":43.6802,"timestamp":1788292800000,"preClose":43.3492,"halted":0,"volume":24001,"hourTrading":{"tag":"盘后","latestPrice":43.6802,"preClose":43.6802,"latestTime":"16:10 EDT","volume":71,"amount":3105.24109,"timestamp":1788293404786,"change":0,"changeRate":0,"amplitude":0.001369},"delay":0,"changeRate":0.007635665710093749,"floatShares":4839999,"shares":4839999,"eps":0,"marketStatus":"Post-Mkt","change":0.331,"latestTime":"09-01 18:37:48 EDT","open":43.54,"high":43.73,"low":43.2799,"amount":1044859,"amplitude":0.010383,"askPrice":65.16,"askSize":200,"bidPrice":38.93,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1692158400000,"exchange":"NASDAQ","adjPreClose":43.3492,"sharesOutstanding":4310000,"nav":43.34,"aum":209765600,"dividendRate":0.000449,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.6802,"preClose":43.6802,"latestTime":"16:10 EDT","volume":71,"amount":3105.24109,"timestamp":1788293404786,"change":0,"changeRate":0,"amplitude":0.001369},"volumeRatio":1.143351},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","floatShares":4839999,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.143351,"shares":4839999,"dividePrice":0.0196,"high":43.73,"amplitude":0.010383,"preClose":43.3492,"low":43.2799,"week52Low":26.52,"pbRate":"--","week52High":47,"institutionHeld":0,"latestPrice":43.6802,"committee":-0.333333,"eps":0,"divideRate":0.000449,"volume":24001,"delay":0,"ttmEps":0,"open":43.54,"prevYearClose":34.7203,"prevWeekClose":43.52,"prevMonthClose":43.3492,"prevQuarterClose":41.24,"fiveDayClose":45.2357,"twentyDayClose":41.64,"sixtyDayClose":36.4294},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANC\",params:#limit:5,,,undefined,":[{"date":"2025-12-10","symbol":"CANC","amount":0.0195905,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-11","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-11"},{"date":"2024-12-11","symbol":"CANC","amount":0.72827,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"},{"date":"2023-12-13","symbol":"CANC","amount":0.149112,"announcedDate":"2023-12-12","type":"dividend","market":"US","newRecordDate":"2023-12-14","defaultRemindTime":1702477800000,"name":"TEMA ONCOLOGY ETF","recordDate":"2023-12-15","payableDate":"2023-12-14","currency":"USD","dateTimestamp":1702443600000,"payDate":"2023-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-13","recordDate":"2023-12-14","paymentDate":"2023-12-15","value":0.149112,"currency":"USD"},{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.72827,"currency":"USD"},{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-11","value":0.0195905,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662812320","title":"Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55","url":"https://stock-news.laohu8.com/highlight/detail?id=2662812320","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662812320?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:29","pubTimestamp":1787844592,"startTime":"0","endTime":"0","summary":"Eli Lilly (NYSE: LLY) reported new independent real-world evidence that its obesity treatment Zepbound (tirzepatide) is linked to lower overall healthcare costs for adults over 55 with obesity.\nThe analysis indicates these cost savings appear as early as 12 months after starting Zepbound treatment in this older patient group.\nThe findings focus on total healthcare spending rather than drug costs alone and suggest a potential economic advantage for Zepbound in routine clinical use.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-says-zepbound-cuts-healthcare-costs-for-adults","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-says-zepbound-cuts-healthcare-costs-for-adults","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015952.SGD","SG9999014906.USD","LU1023059063.AUD","SG9999014880.SGD","SG9999001176.SGD","SG9999015945.SGD","LU0122379950.USD","LU2237443382.USD","LU1629891620.HKD","IE00B4R5TH58.HKD","LU2750360997.AUD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","LU0820561818.USD","LU0353189680.USD","LU0882574055.USD","LLII","LU2602419157.SGD","SGXZ99366536.SGD","LU0882574139.USD","LU1291159041.SGD","LU2265009873.SGD","LU2461242641.AUD","LU1868836591.USD","BK4585","LU2111349929.HKD","LU2360106947.USD","IE00B7KXQ091.USD","LU2552382215.SGD","IE0009355771.USD","LU0289739699.SGD","LU2106854487.HKD","LU2168564149.EUR","LU2361044865.SGD","IE00BWXC8680.SGD","LU2361045086.USD","SGXZ51526630.SGD","LU0823416689.USD","GB00BDT5M118.USD","LU0203202063.USD","LU0471298694.HKD","LU2089984988.USD","LU0787776722.HKD","LU0417517546.SGD","LU1061106388.HKD","LU1035775433.USD","TMED","SG9999018857.SGD","FHLC","IE00BFTCPJ56.SGD","LU2237443549.SGD","ELIL","LU2237443465.HKD","LU2236285917.USD","LU0320765992.SGD","LU2324357040.USD","LU0345770993.USD","LLY","LU0640476718.USD","LU0456855351.SGD","IE00BKDWB100.SGD","LLYX","RXL","JDOC","BK4516","LU0058720904.USD","LU1323610961.USD","LU2471134796.USD","THNR","IE00B1XK9C88.USD","LU2462591350.SGD","LU1868837136.USD","LU0320765059.SGD","LU1551013425.SGD","LU0672654240.SGD","IE00B775H168.HKD","LU2168564495.EUR","LU1917777945.USD","PJP","LU0689472784.USD","LU1127390331.HKD","LU1712237335.SGD","LU2108987350.USD","LU0466842654.USD","LU0061475181.USD","LU2750360641.GBP","LU0158827781.USD","LU0820561909.HKD","LU0820562030.AUD","LU0889565916.HKD","LU1267930730.SGD","LU1280957306.USD","LU2271345857.HKD","SG9999014914.USD","BK4533","LU0266013472.USD","IE00BJJMRZ35.SGD","CURE","LU0097036916.USD","LU1623119135.USD","ILDR","BK4007","LU2756315318.SGD","LU2023251221.USD","LU0964807845.USD","LU1064131342.USD","LU0114720955.EUR","IE00BJJMRX11.SGD","LU1145028129.USD","LU1868836914.USD","SGXZ57979304.SGD","LLYZ","LU2237438978.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","LU2756315664.SGD","IE00BFSS8Q28.SGD","LU1989771016.USD","LU0109391861.USD","LU2491049909.HKD","ELIS","LU0174119429.USD","LU0203201768.USD","FTXH","LU1983299246.USD","LU0238689110.USD","LU0345770308.USD","OZEM","LU1988902786.USD","LU2456880835.USD","LU1974910355.USD","LU2896262040.SGD","BK4534","LU0943347566.SGD","LU1804176565.USD","LU0385154629.USD","LU2237443895.HKD","LU1868837300.USD","LU2491050071.SGD","SG9999015986.USD","LU2357305700.SGD","LU2361044949.HKD","LU0096364046.USD","LU1720051017.SGD","AGNG","LU1979441026.SGD","LU2168564065.EUR","LU2213496289.HKD","LU2028103732.USD","LU0471298777.SGD","LU0198837287.USD","LU2746668974.SGD","IE00BK4W5M84.HKD","LU0006306889.USD","WDNA","LU0133085943.USD","LU0353189763.USD","LU2746668461.USD","LU1057294990.SGD","LU1548497426.USD","LU0234572021.USD","IE0005OL40V9.USD","LU1093756168.USD","LU0432979614.USD","LU2471134879.HKD","IE00BK4W5L77.USD","LU2063271972.USD","LU1720051108.HKD","LU2168563687.JPY","LU2087625088.SGD","SG9999013999.USD","BK4581","IE00B1BXHZ80.USD","LU1366192091.USD","LU0256863811.USD","LU2112291526.USD","LU2237443622.USD","LU2023250504.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0158827948.USD","LU0683600562.USD","LU0354030438.USD","LU1691799644.USD","LU1868836757.USD","LU0316494557.USD","LU2089283258.USD","SG9999001176.USD","HRTS","IE00BN29S564.USD","LU2491050154.USD","LU2417539215.USD","SG9999017495.SGD","MEDX","TRUH","IE0002141913.USD","IE00BJJMRY28.SGD","LU0708995401.HKD","SG9999014898.SGD","GDOC","LU1551013342.USD","IE00BKPKM429.USD","BK4599","LU2211815571.USD","LU2264538146.SGD","LU2468319806.SGD","LU2552382058.USD","LU2471134952.CNY","MEDI","LU2552382132.HKD","LU0786609619.USD","LU2462157665.USD","BK4588","LU1069344957.HKD","LU0823434583.USD","SG9999015978.USD","SG9999018865.SGD","LU0354030511.USD","LU2023250330.USD","IE00B4JS1V06.HKD","SGXZ81514606.USD","IHE","LU0256863902.USD","SGXZ31699556.SGD","PPH","IE0004445239.USD","LU0094547139.USD","CANC","LU0823434740.USD","IE0004445015.USD","LU0106261372.USD","LU1093756325.SGD","LU1232071149.USD","LU1814569148.SGD","LU2089284900.SGD","LU2237443978.SGD","LU2471134523.USD","LU2168564222.USD","LU0323591593.USD","LU0210536198.USD","LU0079474960.USD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704855","title":"Street View: Revolution's Pancreatic Cancer Drug Nod Sparks a 'transformative' Era","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704855","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662704855?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:35","pubTimestamp":1787830554,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Revolution's pancreatic cancer drug nod sparks a 'transformative' era** Revolution Medicines'RVMD.Ogroundbreakingpancreatic cancer drug, Rasonque, received the U.S. FDA approval on W","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O10D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","PTH","BBH","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0009355771.USD","RVMD","IE00BFTCPJ56.SGD","IDNA","IE0009354923.USD","IE0002141913.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4139","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706801","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706801?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Immuneering (IMRX) w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-immuneering-imrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BBH","XBI","IDNA","CANC","IE0009355771.USD","BK4139","XLV","IE0002141913.USD","LU0029874061.USD","IMRX","LU0889565916.HKD","BK4563","IE0009354923.USD","BK4539","LU0109394709.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4588","LU0320765992.SGD","BK4585","RVMD","IE00BFTCPJ56.SGD","BK4137","LU0128526141.USD","BK4581","IE00BJT1NW94.SGD","LABU","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662988724","title":"Revolution Medicines, Inc. : Oppenheimer Raises Target Price to $260 from $230","url":"https://stock-news.laohu8.com/highlight/detail?id=2662988724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662988724?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:38","pubTimestamp":1787798329,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44N0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","RVMD","IE0009354923.USD","CANC","PTH","IE00BJT1NW94.SGD","BBH","IE0009355771.USD","IDNA","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662742399","title":"Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662742399","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662742399?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:34","pubTimestamp":1787776440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Eli Lilly & Co. slipped 3.6% to $1,189.41 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,675.70 and the Dow Jones Industrial Average falling 0.2% to 53,463.88.This was the stock's third consecutive day of losses.Eli Lilly & Co. closed 8.0% below its 52-week high of $1,292.65, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and AbbVie Inc. fell 1.09% to $262.90.Trading volume totaled 3.0 million, compared to the 50-day average of 2.8 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382132.HKD","LU1623119135.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU2106854487.HKD","LU2271345857.HKD","LU2552382058.USD","LU1989771016.USD","IXJ","IE00B1BXHZ80.USD","LU2746668974.SGD","XLV","LU0109394709.USD","LU0133085943.USD","RXL","SG9999015952.SGD","LU2471134879.HKD","LU0820561909.HKD","LU2112291526.USD","LU1868836757.USD","LU2089284900.SGD","HRTS","IYH","IE00BFTCPJ56.SGD","LU2896262040.SGD","LU0823434740.USD","LU1691799644.USD","LU1366192091.USD","THNR","LU0006306889.USD","LU1064131342.USD","IHE","SGXZ99366536.SGD","IE0009355771.USD","LU0225283273.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU0174119429.USD","LU1127390331.HKD","LU2023251221.USD","LU2471134796.USD","SGXZ31699556.SGD","LU2237443465.HKD","IE00B7KXQ091.USD","LU0882574139.USD","LU0353189763.USD","LU0708995401.HKD","LU0198837287.USD","SG9999014906.USD","CANC","BK4516","LU0096364046.USD","LU0417517546.SGD","LU2357305700.SGD","IE00B4JS1V06.HKD","LU1988902786.USD","LU0820561818.USD","BK4588","OZEM","LU2491050071.SGD","LU0256863811.USD","LU0689472784.USD","LU2237443895.HKD","LU2361044949.HKD","SG9999015978.USD","LU1267930730.SGD","SG9999014898.SGD","IE00BFSS7M15.SGD","LU2491050154.USD","LU2552382215.SGD","LU0114720955.EUR","LU0471298777.SGD","CURE","LU0203201768.USD","LU2237443622.USD","LU2023250504.SGD","LU2756315318.SGD","IE00BJJMRZ35.SGD","SG9999014914.USD","LU0122379950.USD","LU1979441026.SGD","SG9999015945.SGD","LU2461242641.AUD","LU1232071149.USD","LU0158827781.USD","LU1291159041.SGD","LLYZ","LU0353189680.USD","SG9999001176.SGD","LU1804176565.USD","LU0203202063.USD","LU0787776722.HKD","LU2108987350.USD","SG9999018857.SGD","SGXZ57979304.SGD","LU2211815571.USD","LU0345770308.USD","IE00B1XK9C88.USD","LU2087625088.SGD","SG9999001176.USD","LU1868836591.USD","LU1720051017.SGD","ELIL","LU2063271972.USD","LU0320765059.SGD","LU0385154629.USD","LU2168564495.EUR","LU1983299246.USD","IE00B2B36J28.USD","LU1061106388.HKD","BK4585","FHLC","LU2462157665.USD","IE00BJJMRY28.SGD","LU1868836914.USD","LU0466842654.USD","LU0354030438.USD","LU1720051108.HKD","LU1323610961.USD","SG9999014880.SGD","LU2089984988.USD","LU0683600562.USD","LU2456880835.USD","SG9999018865.SGD","LU0094547139.USD","LU2111349929.HKD","PPH","TMED","LU1023059063.AUD","LU0238689110.USD","LU0345770993.USD","LU2746668461.USD","LU2361045086.USD","LU2089283258.USD","LU0943347566.SGD","LU1974910355.USD","LU2237443549.SGD","IE00BJJMRX11.SGD","LU2471134523.USD","LU0456855351.SGD","BK4007","IE0004445239.USD","LU0061475181.USD","FTXH","LU1868837136.USD","LU1551013425.SGD","LU2168564065.EUR","LU0097036916.USD","AGNG","BK4599","LU0889565916.HKD","BK4534","LU0266013472.USD","GB00BDT5M118.USD","SGXZ51526630.SGD","LU0640476718.USD","BK4533","MEDI","LU2602419157.SGD","LU1548497426.USD","LU2028103732.USD","LU1551013342.USD","LLII","LU0289739699.SGD","LU1093756325.SGD","WDNA","LU0079474960.USD","IE0001KFT4U8.USD","LU0320765992.SGD","LU1814569148.SGD","LU1917777945.USD","LU2168563687.JPY","ILDR","LU2468319806.SGD","IE00B775H168.HKD","LU0210536198.USD","LU1035775433.USD","LU2756315664.SGD","LU2264538146.SGD","JDOC","LU0820562030.AUD","LU0109391861.USD","LLY","LU0786609619.USD","LU0158827948.USD","LU0106261372.USD","LU0432979614.USD","IE00BN29S564.USD","LLYX","LU1280957306.USD","LU2750360641.GBP","LU0058720904.USD","LU2168564222.USD","ELIS","LU2265009873.SGD","IE00BKDWB100.SGD","LU2324357040.USD","LU0823434583.USD","SG9999013999.USD","IE0005OL40V9.USD","LU0823416689.USD","LU1712237335.SGD","LU2213496289.HKD","LU2462591350.SGD","LU0354030511.USD","LU1868837300.USD","BK4581","LU2237438978.USD","LU2417539215.USD","LU2023250330.USD","LU1145028129.USD","LU1629891620.HKD","IE0004445015.USD","LU0256863902.USD","LU0672654240.SGD","LU2168564149.EUR","LU2361044865.SGD","TRUH","LU0471298694.HKD","VHT","IE00BK4W5M84.HKD","LU0964807845.USD","LU1069344957.HKD","LU2750360997.AUD","SGXZ81514606.USD","IE00BWXC8680.SGD","LU2237443382.USD","IE00BKPKM429.USD","LU0234572021.USD","LU0323591593.USD","LU2471134952.CNY","LU0316494557.USD","IE00BK4W5L77.USD","LU2236285917.USD","MEDX","MHIP","PJP","LU1093756168.USD","IE0002141913.USD","IE00BFSS8Q28.SGD","LU0882574055.USD","LU2237443978.SGD","LU2491049909.HKD","SG9999015986.USD","SG9999017495.SGD","IE00BJLML261.HKD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662497867","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662497867","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662497867?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:07","pubTimestamp":1787771265,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  down 0.9%.The iShares Biotechnology ETF  decreased 0.5%.In corporate news, Eli Lilly  said Wednesday that a real-world study showed sustained use of its weight-management drug Zepbound was associated with lower healthcare costs among adults older than 55 with overweight or obesity, compared with similar untreated adults. Lilly shares were down 3.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999018857.SGD","LU1712237335.SGD","THNR","IE00BJT1NW94.SGD","TRUH","BK4534","IE00BJJMRZ35.SGD","LU0417517546.SGD","LU0323591593.USD","LU2237438978.USD","BK4533","LU0345770308.USD","IE00BJJMRY28.SGD","LU2023250330.USD","LU0058720904.USD","LU0289739699.SGD","LU0079474960.USD","LU2089284900.SGD","LU1551013425.SGD","FTXH","LU1814569148.SGD","LU2461242641.AUD","BK4007","LU0820562030.AUD","LU1974910355.USD","LU0133085943.USD","LU0466842654.USD","LU2237443622.USD","MEDX","PPH","IE00B7KXQ091.USD","LU2471134879.HKD","SG9999015986.USD","LU0786609619.USD","FHLC","SG9999015952.SGD","SGXZ99366536.SGD","LU0823434583.USD","LU1035775433.USD","LU0683600562.USD","LU2237443895.HKD","LU1868836757.USD","LU2111349929.HKD","IE0001KFT4U8.USD","LU0787776722.HKD","LU1323610961.USD","LU2896262040.SGD","LU0354030438.USD","LU0882574055.USD","LU2417539215.USD","IE00BJJMRX11.SGD","LU2112291526.USD","LU1551013342.USD","LU1093756168.USD","LU1629891620.HKD","LU2471134796.USD","MEDI","LU0225283273.USD","WDNA","SG9999014906.USD","SGXZ31699556.SGD","LU0964807845.USD","LU2491049909.HKD","IE00BKPKM429.USD","LU2756315664.SGD","MHIP","IE00B1XK9C88.USD","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2089984988.USD","LU1023059063.AUD","LU2361044865.SGD","LU2028103732.USD","RXL","LU2357305700.SGD","LU1989771016.USD","ILDR","LU2087625088.SGD","LLYZ","IE00BJLML261.HKD","LU1061106388.HKD","LU0823434740.USD","ELIS","LU2264538146.SGD","IBB","LU0094547139.USD","LU0471298694.HKD","IE00B1BXHZ80.USD","LU2746668461.USD","LU2750360641.GBP","SG9999001176.SGD","LU2168564149.EUR","LLII","LU0106261372.USD","IE00B2B36J28.USD","LU2756315318.SGD","LU0385154629.USD","PJP","SG9999018865.SGD","LU0345770993.USD","LU2211815571.USD","LU2265009873.SGD","SGXZ51526630.SGD","LU2471134952.CNY","LU1691799644.USD","BK4588","LU0203201768.USD","LU2237443978.SGD","LU2361044949.HKD","LU2236285917.USD","IE00BFSS7M15.SGD","LU2168564495.EUR","LU0320765059.SGD","LU0158827948.USD","LU2213496289.HKD","IE00B4JS1V06.HKD","LU2237443549.SGD","LU2108987350.USD","OZEM","LU0210536198.USD","VHT","LU0109394709.USD","LU0316494557.USD","LU0672654240.SGD","LU2360106947.USD","LU2468319806.SGD","LU2552382215.SGD","IE00B775H168.HKD","LU2023251221.USD","LU0198837287.USD","LU2750360997.AUD","SGXZ57979304.SGD","LU0354030511.USD","LU0109391861.USD","LU0943347566.SGD","LU0353189763.USD","LU1057294990.SGD","LU1069344957.HKD","LU1720051017.SGD","LU2168564065.EUR","LU2361045086.USD","LU0174119429.USD","LU1979441026.SGD","BK4516","LU2491050154.USD","IE00BFTCPJ56.SGD","HRTS","IE0004445239.USD","SG9999014898.SGD","LU2063271972.USD","XBI","LU1868837136.USD","LU0320765992.SGD","TMED","LU0256863811.USD","CURE","LU2237443465.HKD","LU0097036916.USD","SG9999001176.USD","BK4581","LU1064131342.USD","LU1280957306.USD","LU1127390331.HKD","BK4599","LU0820561818.USD","SG9999014914.USD","LU1804176565.USD","LU1093756325.SGD","LU1548497426.USD","LU2746668974.SGD","IE0002141913.USD","LU2168564222.USD","IE0005OL40V9.USD","IE00BWXC8680.SGD","IE00BK4W5L77.USD","IYH","LU2462157665.USD","LU2552382132.HKD","IXJ","IE0004445015.USD","IE00BN29S564.USD","LU2271345857.HKD","LABU","LU0006306889.USD","JDOC","LU0353189680.USD","LU0234572021.USD","LU2237443382.USD","LU0158827781.USD","ELIL","LU1145028129.USD","LU0456855351.SGD","LU0708995401.HKD","LU2168563687.JPY","LU1988902786.USD","LU2471134523.USD","LU0238689110.USD","GB00BDT5M118.USD","LU0432979614.USD","LU2456880835.USD","SG9999014880.SGD","LU0203202063.USD","LU0640476718.USD","LLY","LU1868836591.USD","LU1868836914.USD","GDOC","LU0471298777.SGD","LU2106854487.HKD","AGNG","LU1291159041.SGD","LU0266013472.USD","LU1623119135.USD","BK4585","LU2324357040.USD","LU2552382058.USD","LU2462591350.SGD","SG9999017495.SGD","LU0882574139.USD","LU2089283258.USD","LU0122379950.USD","LU0820561909.HKD","IE00BFSS8Q28.SGD","LU1983299246.USD","SG9999013999.USD","LU0114720955.EUR","LU2491050071.SGD","SG9999015978.USD","LU1868837300.USD","LU0889565916.HKD","LU0096364046.USD","LU1232071149.USD","LU2023250504.SGD","LU1917777945.USD","LU0823416689.USD","LU0061475181.USD","IE00BK4W5M84.HKD","LU0256863902.USD","LLYX","LU0689472784.USD","LU2602419157.SGD","SG9999015945.SGD","XLV","IE00BKDWB100.SGD","SGXZ81514606.USD","LU1267930730.SGD","IE0009355771.USD","IHE","CANC","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BBP","XLVX","BK4585","RSPH","GNMX","MRNY","BK4007","IEIH","FRTY","LABU","PSCH","MEDI","SYNB","BK4588","HRTS","GDOC","03165","MRNX","TECB","BMED","IYH","CANC","IBB","IDNA","TBXU","LFSC","PINK","RHHBY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749358","title":"Revolution Medicines Prices Metastatic Pancreatic Cancer Drug Rasonque at $39,800 a Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749358","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749358?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:20","pubTimestamp":1787768430,"startTime":"0","endTime":"0","summary":"Revolution Medicines'  once-daily oral Rasonque tablets for the treatment of metastatic pancreatic cancer are available in the US at a price of $39,800 for a 30-day supply, the company said Wednesday in a regulatory filing.The US Food and Drug Administration approved Rasonque for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.Price: 215.95, Change: +4.57, Percent Change: +2.16","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","PTH","IE00BFTCPJ56.SGD","IE0002141913.USD","RVMD","LU0109394709.USD","IDNA","IE0009355771.USD","CANC","BK4139","IE0009354923.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00B2B36J28.USD","LU0320765992.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746776","title":"Revolution Medicines to Charge $39,800 a Month for Pancreatic Cancer Drug, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746776","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746776?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:02","pubTimestamp":1787767375,"startTime":"0","endTime":"0","summary":"Price: 215.72, Change: +4.34, Percent Change: +2.05","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CANC","LU0109394709.USD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IDNA","IE00BJJMRZ35.SGD","PTH","IE00B4R5TH58.HKD","IE0009354923.USD","IE0009355771.USD","LU0889565916.HKD","BBH","BK4139","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662462057","title":"Revolution Medicines - Rasonque is NOW Commercially Available in the U.S. at a Wholesale Acquisition Cost of $39,800 for a 30-Day Supply - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2662462057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662462057?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:56","pubTimestamp":1787766961,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CANC","LU0889565916.HKD","BK4139","IE00BFTCPJ56.SGD","IE0009354923.USD","IDNA","IE0002141913.USD","RVMD","PTH","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746411","title":"Revolution Medicines Posts Investor Presentation on Rasonque FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746411","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766356,"startTime":"0","endTime":"0","summary":"Revolution Medicines posts investor presentation on RASONQUE FDA approvalRevolution Medicines released an investor presentation covering U.S. FDA approval of RASONQUE (daraxonrasib) for metastatic pan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL4qMXCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","PTH","BBH","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0009355771.USD","RVMD","IE00BFTCPJ56.SGD","IDNA","IE0009354923.USD","IE0002141913.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4139","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","CANC","IEIH","RVMD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0009354923.USD","PTH","MEDI","BBP","BK4585","IE00BJJMRZ35.SGD","LABU","MRNX","TBXU","IE00B4R5TH58.HKD","NVIB","IE0009355771.USD","IE00BFTCPJ56.SGD","RSPH","PSCH","GNMX","LFSC","LU0320765992.SGD","BK4588","IE0002141913.USD","TECB","IYH","XLVX","IDNA","PINK","BMED","SYNB","IBB","LU0889565916.HKD","FRTY","BK4139","GDOC","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","LU0109394709.USD","PINK","MEDI","IYH","BK4585","MRNX","BK4588","IE00B2B36J28.USD","RVMD","LFSC","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","GNMX","LABU","IEIH","BBP","LU0320765992.SGD","XLVX","IE0009355771.USD","IBB","FRTY","NVIB","SYNB","BBH","TBXU","IDNA","MRNY","CANC","IE0009354923.USD","LU0889565916.HKD","PTH","GDOC","PSCH","TECB","IE00BJT1NW94.SGD","RSPH","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745207","title":"Revolution Medicines, - Rasonque 300 Mg Once-Daily Oral Tablets NOW Available in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745207?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA6XRCYX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","LU0320765992.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0109394709.USD","IE00B2B36J28.USD","CANC","BK4139","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","RVMD","IE00BJJMRZ35.SGD","IDNA","BBH","IE0009354923.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662452007","title":"U.S. FDA Approves Revolution Medicines’ Rasonque™ (Daraxonrasib), the First Broad Ras-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662452007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662452007?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA6XRCYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","IE0002141913.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU0889565916.HKD","LU0109394709.USD","PTH","RVMD","CANC","IE00BFTCPJ56.SGD","IE0009354923.USD","BBH","IE00B4R5TH58.HKD","BK4139","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759746","title":"U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759746","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763540,"startTime":"0","endTime":"0","summary":"RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent syste","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351615/0/en/u-s-fda-approves-revolution-medicines-rasonque-daraxonrasib-the-first-broad-ras-targeted-medicine-in-metastatic-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","BK4009","LU2487616109.SGD","BK4613","LABU","LU0724618433.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","EMA","TTDU","HR","BK4225","LU0210528500.USD","BK4585","BK4588","LU1861220033.SGD","IE00BZ199S13.USD","LU1720051017.SGD","LU0320765992.SGD","IE0002141913.USD","LU1854103824.USD","LU0124384867.USD","PTH","LU0889565916.HKD","BK4023","LU0053671581.USD","SRET","PFS","IE0009355771.USD","BK4141","ITT","BK4139","BK4605","RVMD","ON","LU1861219969.SGD","ONX","TTD","BBH","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2360107325.USD","IDNA","LU1978683503.SGD","IE0009354923.USD","BK4512","L","IE00BD6J9T35.USD","ONG","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745169","title":"Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745169","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745169?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:30","pubTimestamp":1787761857,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The study A Master Protocol for Phase 1 Clinical Trials of Multip...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lilly-expands-alzheimers-pipeline-with-new-amyloid-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lilly-expands-alzheimers-pipeline-with-new-amyloid-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELIS","LU1623119135.USD","LU0889565916.HKD","SG9999014914.USD","LU2237443549.SGD","SGXZ81514606.USD","LU2552382058.USD","LU1917777945.USD","LU2271345857.HKD","LLY","JDOC","MHIP","LU0385154629.USD","LU0289739699.SGD","LU2211815571.USD","LU2361044949.HKD","LU0345770993.USD","LU1323610961.USD","LU2361045086.USD","LU1551013425.SGD","MEDX","LU0320765059.SGD","IE00BFTCPJ56.SGD","SG9999015952.SGD","LU2089283258.USD","SG9999017495.SGD","CANC","LU0786609619.USD","LU2089984988.USD","LU1720051108.HKD","SG9999001176.USD","LU1127390331.HKD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2168564222.USD","LU2168564065.EUR","LU2168564149.EUR","LU0079474960.USD","LU2357305700.SGD","IE0004445015.USD","LU2756315318.SGD","IE00BK4W5L77.USD","BK4007","OZEM","LU0133085943.USD","BK4581","LU0203201768.USD","RXL","LU0097036916.USD","IE00BJLML261.HKD","IYH","LU0109394709.USD","GDOC","LU0106261372.USD","LU1551013342.USD","IE00BKPKM429.USD","LU2112291526.USD","LU1804176565.USD","IE00BKDWB100.SGD","LU2324357040.USD","AGNG","LU1548497426.USD","LU2237443895.HKD","LU1057294990.SGD","LU0417517546.SGD","HRTS","LU2023250504.SGD","LU2746668461.USD","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0234572021.USD","IE00B2B36J28.USD","LU0943347566.SGD","LU1023059063.AUD","LU0114720955.EUR","LU1232071149.USD","LU2106854487.HKD","LU0456855351.SGD","LU2028103732.USD","LU1280957306.USD","LU0354030438.USD","LU2462591350.SGD","IE00B7KXQ091.USD","IE00B4JS1V06.HKD","LU1291159041.SGD","BK4534","LU1868837300.USD","LU2023251221.USD","LU2471134523.USD","IE0002141913.USD","IE00B1XK9C88.USD","WDNA","SGXZ99366536.SGD","SG9999014898.SGD","PPH","LU0820562030.AUD","LU1035775433.USD","LU2491049909.HKD","SGXZ57979304.SGD","LU2417539215.USD","LU2462157665.USD","LU2471134796.USD","LU2264538146.SGD","LU2360106947.USD","IE00BWXC8680.SGD","IE00BJT1NW94.SGD","THNR","LU0109391861.USD","SG9999018857.SGD","LU1093756325.SGD","LU1868837136.USD","LU2237443622.USD","IXJ","LU0882574055.USD","LU0158827948.USD","LU0820561909.HKD","LU2023250330.USD","LU2468319806.SGD","VHT","IE00BN29S564.USD","LU1989771016.USD","SG9999014906.USD","LU0823434740.USD","LU0672654240.SGD","LU2456880835.USD","LU0266013472.USD","LU2896262040.SGD","LU1868836591.USD","PJP","TMED","LU1868836914.USD","LU2491050154.USD","LU2108987350.USD","LU1979441026.SGD","LU0006306889.USD","BK4585","LU0820561818.USD","LU0225283273.USD","IE0005OL40V9.USD","LU0882574139.USD","LU1145028129.USD","CURE","IE00BFSS7M15.SGD","IE0004445239.USD","LU0471298777.SGD","BK4516","LU2168563687.JPY","LU1712237335.SGD","SG9999014880.SGD","LU2461242641.AUD","LLYX","LU0096364046.USD","LU0320765992.SGD","IE0001KFT4U8.USD","LU0466842654.USD","LU2237443978.SGD","SGXZ51526630.SGD","LU1064131342.USD","LU1691799644.USD","ELIL","LU0316494557.USD","LU0061475181.USD","LU1974910355.USD","SG9999015986.USD","LU0256863811.USD","LU2168564495.EUR","LU0238689110.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","FHLC","LU1868836757.USD","LLYZ","SG9999013999.USD","LU0345770308.USD","SG9999001176.SGD","TRUH","LU0964807845.USD","LU0122379950.USD","LU2471134879.HKD","LU2552382215.SGD","LU0640476718.USD","LU2552382132.HKD","LU2750360997.AUD","LU0203202063.USD","LU1629891620.HKD","LU2750360641.GBP","LU0683600562.USD","LU2361044865.SGD","LU0354030511.USD","IE00BK4W5M84.HKD","LU2089284900.SGD","SGXZ31699556.SGD","BK4588","LU0689472784.USD","BK4533","LU0353189680.USD","LU2237443465.HKD","SG9999015978.USD","LU0823434583.USD","LU0708995401.HKD","BK4599","LU2237438978.USD","LU2491050071.SGD","LU0256863902.USD","LU0353189763.USD","LLII","MEDI","GB00BDT5M118.USD","LU2213496289.HKD","LU1366192091.USD","LU2471134952.CNY","LU0432979614.USD","LU0174119429.USD","IE0009355771.USD","LU0058720904.USD","LU0158827781.USD","LU1069344957.HKD","LU1814569148.SGD","LU0787776722.HKD","LU1061106388.HKD","IE00BJJMRX11.SGD","LU2111349929.HKD","XLV","IE00BJJMRY28.SGD","LU0471298694.HKD","LU1267930730.SGD","FTXH","IHE","LU2265009873.SGD","LU1988902786.USD","LU0323591593.USD","LU0094547139.USD","ILDR","LU0198837287.USD","LU1983299246.USD","LU0210536198.USD","LU1093756168.USD","LU2063271972.USD","LU2237443382.USD","LU2756315664.SGD","SG9999015945.SGD","SG9999018865.SGD","LU2602419157.SGD","IE00BFSS8Q28.SGD","LU1720051017.SGD","LU2746668974.SGD","IE00B775H168.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662743178","title":"Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662743178","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662743178?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:40","pubTimestamp":1787758836,"startTime":"0","endTime":"0","summary":"The test has already been approved in Europe.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-in-focus-as-alzheimer-blood-test-gets-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-in-focus-as-alzheimer-blood-test-gets-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","LU2087625088.SGD","PPH","IE00B1BXHZ80.USD","LU2237443549.SGD","IE00BJJMRZ35.SGD","IE00BKPKM429.USD","LU0820561818.USD","LU0158827781.USD","LU1804176565.USD","LU1868837300.USD","SG9999014898.SGD","LU2471134879.HKD","IE00BFTCPJ56.SGD","IHE","IE0009355771.USD","LU0174119429.USD","LU2265009873.SGD","LU2750360641.GBP","LU2491050071.SGD","LU1814569148.SGD","IE00B4R5TH58.HKD","LU2756315664.SGD","LU0323591593.USD","IE00BK4W5M84.HKD","LU2023251221.USD","LU0353189680.USD","LU0471298694.HKD","LLII","LU1061106388.HKD","LU1548497426.USD","SG9999015952.SGD","IE00B7KXQ091.USD","LU0109394709.USD","ELIL","LU1712237335.SGD","SGXZ31699556.SGD","LLYX","IE00BJJMRX11.SGD","IYH","LU1551013342.USD","LU2089984988.USD","MEDX","IE00BJJMRY28.SGD","AGNG","LU2063271972.USD","LU2168564149.EUR","IE00BJLML261.HKD","LU0109391861.USD","LU2168564495.EUR","LU0256863811.USD","PJP","LU0820562030.AUD","SGXZ81514606.USD","HRTS","LU2089283258.USD","LU0889565916.HKD","BK4007","LU2361044949.HKD","IE00BKDWB100.SGD","GB00BDT5M118.USD","LU2456880835.USD","IE0001KFT4U8.USD","LU0058720904.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU2602419157.SGD","CURE","IE00B1XK9C88.USD","LU1267930730.SGD","LU2552382058.USD","LU0964807845.USD","BK4581","LU1093756325.SGD","LU2462157665.USD","LU2168564222.USD","OZEM","LU0823434583.USD","LU1057294990.SGD","LU0316494557.USD","VHT","LU0943347566.SGD","LU1868837136.USD","THNR","LU1988902786.USD","LU2028103732.USD","SGXZ57979304.SGD","LU2471134523.USD","CANC","LU0210536198.USD","LU0672654240.SGD","LU1093756168.USD","SG9999017495.SGD","LU0158827948.USD","LU0320765992.SGD","RXL","LU2491050154.USD","IE00BK4W5L77.USD","LU1720051108.HKD","LU0417517546.SGD","LU1983299246.USD","LU2750360997.AUD","LU2237443465.HKD","LU0787776722.HKD","LU0471298777.SGD","LU2023250330.USD","LU0094547139.USD","LU1917777945.USD","LU2168564065.EUR","LU2552382132.HKD","LLYZ","LU1366192091.USD","IE00BN29S564.USD","IE0004445239.USD","SG9999015986.USD","LU1064131342.USD","LU0432979614.USD","LU2237443895.HKD","LU1280957306.USD","LU2361044865.SGD","BK4533","LU1989771016.USD","LU2237443978.SGD","IE00B2B36J28.USD","LU0133085943.USD","LU2471134796.USD","IE00B4JS1V06.HKD","IE00BWXC8680.SGD","SG9999014906.USD","LU2324357040.USD","IXJ","LU0882574055.USD","LU2896262040.SGD","GDOC","LU1551013425.SGD","LU1868836591.USD","LU2462591350.SGD","IE0002141913.USD","LU0708995401.HKD","LU2360106947.USD","LU0203202063.USD","LU2361045086.USD","LU0823434740.USD","LU0061475181.USD","LU0345770308.USD","LU2271345857.HKD","LU0456855351.SGD","LU1629891620.HKD","SG9999014880.SGD","LU1145028129.USD","BK4516","LU1979441026.SGD","BK4585","LU0354030511.USD","SG9999015978.USD","LU0683600562.USD","LU0234572021.USD","LU0466842654.USD","BK4599","LU1868836914.USD","LU0256863902.USD","FHLC","LU0354030438.USD","LU2746668974.SGD","IE00B775H168.HKD","SG9999018865.SGD","TMED","BK4588","LU1069344957.HKD","IE0004445015.USD","LU0689472784.USD","LU1720051017.SGD","LU2211815571.USD","LU2491049909.HKD","SG9999001176.SGD","SG9999018857.SGD","LU0122379950.USD","LU1127390331.HKD","LU2756315318.SGD","LU0097036916.USD","LU0225283273.USD","LU2106854487.HKD","LU2264538146.SGD","LU1232071149.USD","LU0786609619.USD","LU2168563687.JPY","FTXH","LU2461242641.AUD","LU2237438978.USD","LU2468319806.SGD","LU0198837287.USD","LU2112291526.USD","IE00BFSS8Q28.SGD","LU0006306889.USD","SGXZ99366536.SGD","LU0266013472.USD","LU1035775433.USD","ELIS","JDOC","LU2357305700.SGD","LU0345770993.USD","LU2746668461.USD","LU0289739699.SGD","LU0882574139.USD","LU2111349929.HKD","BK4534","LU0114720955.EUR","LU2237443382.USD","LU1623119135.USD","LU0385154629.USD","ILDR","MEDI","LU0320765059.SGD","LU0820561909.HKD","LU0353189763.USD","LU0203201768.USD","WDNA","LU2213496289.HKD","LLY","LU2417539215.USD","IE0005OL40V9.USD","LU2089284900.SGD","LU2552382215.SGD","LU1323610961.USD","SG9999013999.USD","XLV","LU0096364046.USD","LU2108987350.USD","LU1023059063.AUD","LU2236285917.USD","LU0079474960.USD","LU0238689110.USD","LU1974910355.USD","LU1868836757.USD","MHIP","LU2471134952.CNY","LU0106261372.USD","IE00BFSS7M15.SGD","LU1691799644.USD","SG9999014914.USD","SG9999015945.SGD","LU1291159041.SGD","LU0640476718.USD","LU2237443622.USD","TRUH","SGXZ51526630.SGD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748785","title":"FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748785?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:18","pubTimestamp":1787757480,"startTime":"0","endTime":"0","summary":"For four decades, cancer researchers fought to disable a stubborn mutation that made pancreatic cancer a death sentence-to little avail.Now, doctors have a medicine that targets the mutation. The Food","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","IE00B2B36J28.USD","BK4139","IE0002141913.USD","CANC","BBH","BK4585","RVMD","IDNA","IE0009355771.USD","BK6515","LU0320765992.SGD","LU0889565916.HKD","PTH","IE00BJJMRZ35.SGD","BK6027","RDR.SI","BK4588","IE0009354923.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662107077","title":"US FDA Approves Revolution Medicines' Pancreatic Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662107077","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662107077?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:43","pubTimestamp":1787755405,"startTime":"0","endTime":"0","summary":"US FDA approves Revolution Medicines' pancreatic cancer drugAug 26 (Reuters)-The U.S. Food and Drug Administration approved Revolution Medicines'RVMD.Otargeted drug for metastatic pancreatic cancer, the regulator said on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N16Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BBH","BK4139","IDNA","IE0009355771.USD","PTH","IE00B4R5TH58.HKD","RVMD","LU0320765992.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0009354923.USD","CANC","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}